Radioiodine Therapy Improves Relative Survival Rates of Differentiated Thyroid Cancer Patients
April 24, 2025
April 24, 2025
RESTON, Virginia, April 24 [Category: Medical] -- The Society of Nuclear Medicine and Molecular Imaging issued the following news release:
* * *
Radioiodine Therapy Improves Relative Survival Rates of Differentiated Thyroid Cancer Patients
Media Contact:
Rebecca Maxey
(703) 652-6772
rmaxey@snmmi.org
#
Survival benefit prevails in low-, intermediate-, and high-risk subgroups
* * *
Radioiodine Therapy Improves Relative Survival Rates of Differentiated Thyroid Cancer Patients
Media Contact:
Rebecca Maxey
(703) 652-6772
rmaxey@snmmi.org
#
Survival benefit prevails in low-, intermediate-, and high-risk subgroups